JIC
IRMD icon

Johnson Investment Counsel’s iRadimed IRMD Stock Holding History

Johnson Investment Counsel’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Buy
26,129
+5,690
+28% +$518K 0.02% 289
2026
Q1 		$1.97M Sell
20,439
-5,403
-21% -$540K 0.02% 331
2025
Q4 		$2.51M Hold
25,842
– – 0.02% 273
2025
Q3 		$1.84M Buy
25,842
+187
+0.7% +$12.5K 0.02% 322
2025
Q2 		$1.53M Buy
+25,655
New +$1.41M 0.01% 347

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Johnson Investment Counsel's IRMD Position: Q2 2026 in Review

Johnson Investment Counsel increased its iRadimed (IRMD) stake by 28% in Q2 2026, buying an estimated $518K and bringing the position to 26,129 shares worth $2.5M. The position accounts for 0.02% of the portfolio, ranked #289.

Johnson Investment Counsel first reported a position in IRMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.51M in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Johnson Investment Counsel held 26,129 shares of iRadimed worth $2.5M as of Q2 2026.
  • Johnson Investment Counsel bought 5,690 iRadimed shares in Q2 2026, an estimated $518K.
  • iRadimed made up 0.02% of Johnson Investment Counsel's portfolio in Q2 2026, its #289 holding.
  • Johnson Investment Counsel first reported a position in iRadimed in Q2 2025 and has held it in 5 quarters since.
  • Johnson Investment Counsel's iRadimed position peaked at $2.51M in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.